Bechi P, Romagnoli P, Panula P, Dei R, Bacci S, Amorosi A, Masini E
Dipartimento di Anatomia Umana e Istologia, Università di Firenze, Florence, Italy.
Dig Dis Sci. 1995 Oct;40(10):2207-13. doi: 10.1007/BF02209008.
Gastric mucosal histamine content, enterochromaffin-like cell density, and mast cell density were studied in 13 subjects under omeprazole therapy, 13 partially gastrectomized subjects with a Billroth II reconstruction, 10 partially gastrectomized subjects with a Roux-en-Y reconstruction, and 9 control subjects. Histamine content was significantly greater both in the subjects with higher gastrinemic levels (omeprazole-treated subjects) and those with more abundant enterogastric reflux (Billroth II subjects) than in controls. Enterochromaffin-like cell density was significantly greater in the omeprazole subjects than in each of the other groups. Mast cell density was significantly greater in Billroth II subjects than in controls. Serum gastrin levels, mucosal histamine content, and enterochromaffin-like cell density were positively correlated. Gastrin was not correlated to mast cell density. These results support the existence of different control pathways for enterochromaffin-like and mast cells. Moreover, they suggest that enterochromaffin-like cells and mast cells are involved in the regulation of gastric secretion and in gastric mucosal injury-repair mechanisms, respectively, due to histamine release.
对13名接受奥美拉唑治疗的受试者、13名接受毕罗Ⅱ式重建的部分胃切除受试者、10名接受Roux-en-Y重建的部分胃切除受试者以及9名对照受试者的胃黏膜组胺含量、肠嗜铬样细胞密度和肥大细胞密度进行了研究。与对照组相比,胃泌素水平较高的受试者(接受奥美拉唑治疗的受试者)和肠胃反流较多的受试者(毕罗Ⅱ式受试者)的组胺含量均显著更高。奥美拉唑治疗的受试者的肠嗜铬样细胞密度显著高于其他各组。毕罗Ⅱ式受试者的肥大细胞密度显著高于对照组。血清胃泌素水平、黏膜组胺含量和肠嗜铬样细胞密度呈正相关。胃泌素与肥大细胞密度无关。这些结果支持肠嗜铬样细胞和肥大细胞存在不同的控制途径。此外,它们表明,由于组胺释放,肠嗜铬样细胞和肥大细胞分别参与胃分泌的调节和胃黏膜损伤修复机制。